{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T21:42:54Z","timestamp":1790977374137,"version":"4.1.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T00:00:00Z","timestamp":1784678400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["kireports.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney International Reports"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.ekir.2026.106991","type":"journal-article","created":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T06:51:57Z","timestamp":1785307917000},"page":"106991","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Peritonitis and Mortality Risks of Gastric Acid Suppressants in Patients Undergoing Peritoneal Dialysis"],"prefix":"10.1016","volume":"11","author":[{"given":"Min","family":"Fan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth K.C.","family":"Man","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X.","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celine S.L.","family":"Chui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X.N.","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther W.Y.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sydney C.W.","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian C.K.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franco W.T.","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ekir.2026.106991_bib1","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1038\/s41581-022-00623-7","article-title":"Epidemiology of peritoneal dialysis outcomes","volume":"18","author":"Bello","year":"2022","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.ekir.2026.106991_bib2","doi-asserted-by":"crossref","first-page":"173","DOI":"10.2147\/IJNRD.S123618","article-title":"Peritoneal dialysis-related peritonitis: challenges and solutions","volume":"11","author":"Salzer","year":"2018","journal-title":"Int J Nephrol Renovasc Dis"},{"key":"10.1016\/j.ekir.2026.106991_bib3","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1053\/j.ajkd.2014.02.025","article-title":"Peritoneal dialysis-related peritonitis: towards improving evidence, practices, and outcomes","volume":"64","author":"Cho","year":"2014","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ekir.2026.106991_bib4","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1111\/sdi.13226","article-title":"Does the use of gastric-acid suppressants increase the risk of peritonitis in patients undergoing peritoneal dialysis? A meta-analysis","volume":"37","author":"Yao","year":"2024","journal-title":"Semin Dial"},{"key":"10.1016\/j.ekir.2026.106991_bib5","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1111\/imj.70128","article-title":"Proton pump inhibitors and peritoneal dialysis-associated peritonitis: a cohort study in Newcastle, Australia","volume":"55","author":"Richards","year":"2025","journal-title":"Intern Med J"},{"key":"10.1016\/j.ekir.2026.106991_bib6","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1080\/0886022X.2022.2129064","article-title":"Proton pump inhibitor usage associates with higher risk of first episodes of pneumonia and peritonitis in peritoneal dialysis patients","volume":"44","author":"Zhang","year":"2022","journal-title":"Ren Fail"},{"key":"10.1016\/j.ekir.2026.106991_bib7","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/imj.15601","article-title":"Proton pump inhibitor use and the risk of peritoneal dialysis associated peritonitis","volume":"53","author":"Walia","year":"2023","journal-title":"Intern Med J"},{"key":"10.1016\/j.ekir.2026.106991_bib8","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1177\/08968608221080586","article-title":"ISPD peritonitis guideline recommendations: 2022 update on prevention and treatment","volume":"42","author":"Li","year":"2022","journal-title":"Perit Dial Int"},{"key":"10.1016\/j.ekir.2026.106991_bib9","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/S1091-255X(00)80032-3","article-title":"Suppression of gastric acid secretion in patients with gastroesophageal reflux disease results in gastric bacterial overgrowth and deconjugation of bile acids","volume":"4","author":"Theisen","year":"2000","journal-title":"J Gastrointest Surg"},{"key":"10.1016\/j.ekir.2026.106991_bib10","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.bbrc.2009.02.109","article-title":"Gastric acid reduction leads to an alteration in lower intestinal microflora","volume":"381","author":"Kanno","year":"2009","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.ekir.2026.106991_bib11","doi-asserted-by":"crossref","first-page":"3905","DOI":"10.1128\/AAC.00522-06","article-title":"Suppression of gastric acid production by proton pump inhibitor treatment facilitates colonization of the large intestine by vancomycin-resistant Enterococcus spp. and Klebsiella pneumoniae in clindamycin-treated mice","volume":"50","author":"Stiefel","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ekir.2026.106991_bib12","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/jcpt.12769","article-title":"Use of gastric-acid suppressants may be a risk factor for enteric peritonitis in patients undergoing peritoneal dialysis: a meta-analysis","volume":"44","author":"Zhong","year":"2019","journal-title":"J Clin Pharm Ther"},{"key":"10.1016\/j.ekir.2026.106991_bib13","doi-asserted-by":"crossref","DOI":"10.1093\/ckj\/sfaf054","article-title":"The impact of gastric acid suppressants on peritonitis risk in peritoneal dialysis patients: a systematic review and meta-analysis","volume":"18","author":"Hsiao","year":"2025","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.ekir.2026.106991_bib14","doi-asserted-by":"crossref","first-page":"370","DOI":"10.34067\/KID.0000000000000325","article-title":"Gastric acid suppression therapy and its association with peritoneal dialysis-associated peritonitis in the Peritoneal Dialysis Outcomes and Practice Patterns Study (PDOPPS)","volume":"5","author":"Goldman","year":"2024","journal-title":"Kidney360"},{"key":"10.1016\/j.ekir.2026.106991_bib15","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1001\/jama.2017.1363","article-title":"Association between dabigatran vs warfarin and risk of osteoporotic fractures among patients with nonvalvular atrial fibrillation","volume":"317","author":"Lau","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.ekir.2026.106991_bib16","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1093\/cid\/ciad491","article-title":"Population sepsis incidence, mortality, and trends in Hong Kong between 2009 and 2018 using clinical and administrative data","volume":"80","author":"Ling","year":"2025","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ekir.2026.106991_bib17","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1002\/pds.4208","article-title":"Validity of major osteoporotic fracture diagnosis codes in the Clinical Data Analysis and Reporting System in Hong Kong","volume":"26","author":"Sing","year":"2017","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.ekir.2026.106991_bib18","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/j.kint.2022.07.018","article-title":"The effectiveness and safety of mRNA (BNT162b2) and inactivated (CoronaVac) COVID-19 vaccines among individuals with chronic kidney diseases","volume":"102","author":"Cheng","year":"2022","journal-title":"Kidney Int"},{"key":"10.1016\/j.ekir.2026.106991_bib19","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1136\/gutjnl-2017-314605","article-title":"Long-term proton pump inhibitors and risk of gastric cancer development after treatment for Helicobacter pylori: a population-based study","volume":"67","author":"Cheung","year":"2018","journal-title":"Gut"},{"key":"10.1016\/j.ekir.2026.106991_bib20","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1093\/ndt\/gfac292","article-title":"Risk of glomerular diseases, proteinuria and hematuria following mRNA (BNT162b2) and inactivated (CoronaVac) SARS-CoV-2 vaccines","volume":"38","author":"Cheng","year":"2023","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.ekir.2026.106991_bib21","doi-asserted-by":"crossref","DOI":"10.1093\/ckj\/sfae118","article-title":"Risk of first peritonitis episode in continuous ambulatory peritoneal dialysis and automated peritoneal dialysis: a population-based study","volume":"17","author":"Cheng","year":"2024","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.ekir.2026.106991_bib22","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1681\/ASN.0000000554","article-title":"Long-term benefits and safety of statins in patients with kidney failure: a target trial emulation study","volume":"36","author":"Cheng","year":"2025","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2026.106991_bib23","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/EDE.0b013e3181c1ea43","article-title":"The hazards of hazard ratios","volume":"21","author":"Hernan","year":"2010","journal-title":"Epidemiology"},{"key":"10.1016\/j.ekir.2026.106991_bib24","series-title":"Applied Longitudinal Data Analysis : Modeling Change and Event Occurrence","author":"Singer","year":"2003"},{"key":"10.1016\/j.ekir.2026.106991_bib25","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1001\/jama.2020.7819","article-title":"Overlap weighting: a propensity score method that mimics attributes of a randomized clinical trial","volume":"323","author":"Thomas","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.ekir.2026.106991_bib26","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1177\/10600280211039240","article-title":"Proton pump inhibitors and the risk of community-acquired pneumonia: an updated meta-analysis","volume":"56","author":"Xun","year":"2022","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.ekir.2026.106991_bib27","doi-asserted-by":"crossref","first-page":"E166","DOI":"10.9778\/cmajo.20140074","article-title":"Proton pump inhibitors and the risk of acute kidney injury in older patients: a population-based cohort study","volume":"3","author":"Antoniou","year":"2015","journal-title":"CMAJ Open"},{"key":"10.1016\/j.ekir.2026.106991_bib28","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1001\/jama.292.16.1955","article-title":"Risk of community-acquired pneumonia and use of gastric acid-suppressive drugs","volume":"292","author":"Laheij","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.ekir.2026.106991_bib29","doi-asserted-by":"crossref","DOI":"10.1136\/bmjebm-2025-114134","article-title":"Safety of proton pump inhibitors: an overview of systematic reviews and meta-analyses","author":"Wang","year":"2026","journal-title":"BMJ Evid Based Med"},{"key":"10.1016\/j.ekir.2026.106991_bib30","doi-asserted-by":"crossref","first-page":"35","DOI":"10.7326\/M18-3667","article-title":"The predictive approaches to treatment effect heterogeneity (PATH) statement","volume":"172","author":"Kent","year":"2020","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ekir.2026.106991_bib31","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1053\/j.gastro.2025.04.025","article-title":"Pharmacomicrobiomics: the role of the gut microbiome in immunomodulation and cancer therapy","volume":"169","author":"Bolte","year":"2025","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ekir.2026.106991_bib32","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1136\/gutjnl-2023-330168","article-title":"Compared to histamine-2 receptor antagonist, proton pump inhibitor induces stronger oral-to-gut microbial transmission and gut microbiome alterations: a randomised controlled trial","volume":"73","author":"Zhu","year":"2024","journal-title":"Gut"},{"key":"10.1016\/j.ekir.2026.106991_bib33","article-title":"Risk of spontaneous bacterial peritonitis associated with gastric Acid suppression","volume":"94","author":"Chang","year":"2015","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.ekir.2026.106991_bib34","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1007\/s43440-023-00489-x","article-title":"Proton pump inhibitor-induced gut dysbiosis and immunomodulation: current knowledge and potential restoration by probiotics","volume":"75","author":"Kiecka","year":"2023","journal-title":"Pharmacol Rep"},{"key":"10.1016\/j.ekir.2026.106991_bib35","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/bph.12107","article-title":"Modulation of neutrophil oxidative burst via histamine receptors","volume":"170","author":"Ciz","year":"2013","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.ekir.2026.106991_bib36","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.jaci.2013.01.013","article-title":"Histamine receptor 2 modifies dendritic cell responses to microbial ligands","volume":"132","author":"Frei","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.ekir.2026.106991_bib37","first-page":"12","article-title":"The ageing gastrointestinal tract","volume":"19","author":"Soenen","year":"2016","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"10.1016\/j.ekir.2026.106991_bib38","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1029948","article-title":"The impact of aging on intestinal mucosal immune function and clinical applications","volume":"13","author":"Zheng","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.ekir.2026.106991_bib39","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0148806","article-title":"Inhibition of gastric acid secretion by H2 receptor antagonistsassociates a definite risk of enteric peritonitis and infectious mortality in patients treated with peritoneal dialysis","volume":"11","author":"Perez-Fontan","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.ekir.2026.106991_bib40","doi-asserted-by":"crossref","DOI":"10.1080\/0886022X.2025.2594258","article-title":"Proton pump inhibitor use and cardiovascular risk, all-cause, and cardiovascular mortality across baseline eGFR categories: a longitudinal study","volume":"47","author":"Zhang","year":"2025","journal-title":"Ren Fail"},{"key":"10.1016\/j.ekir.2026.106991_bib41","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1080\/0886022X.2022.2043903","article-title":"Proton pump inhibitor usage is associated with higher all-cause mortality and CV events in peritoneal dialysis patients","volume":"44","author":"Zeng","year":"2022","journal-title":"Ren Fail"},{"key":"10.1016\/j.ekir.2026.106991_bib42","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1001\/jamainternmed.2015.7193","article-title":"Proton pump inhibitoruse and the risk of chronic kidney disease","volume":"176","author":"Lazarus","year":"2016","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.ekir.2026.106991_bib43","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1001\/archinte.167.9.950","article-title":"Use of proton pump inhibitors and the risk of community-acquired pneumonia: a population-based case-control study","volume":"167","author":"Gulmez","year":"2007","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ekir.2026.106991_bib44","first-page":"1001","article-title":"Clostridium difficile-associated diarrhea and proton pump inhibitor therapy: a meta-analysis","volume":"107","author":"Janarthanan","year":"2012","journal-title":"AmJGastroenterol"},{"key":"10.1016\/j.ekir.2026.106991_bib45","article-title":"Community acquired pneumonia incidence before and after proton pump inhibitor prescription: population based study","volume":"355","author":"Othman","year":"2016","journal-title":"BMJ"}],"container-title":["Kidney International Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468024926032237?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468024926032237?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T09:40:12Z","timestamp":1790934012000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468024926032237"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":45,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S2468024926032237"],"URL":"https:\/\/doi.org\/10.1016\/j.ekir.2026.106991","relation":{},"ISSN":["2468-0249"],"issn-type":[{"value":"2468-0249","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Peritonitis and Mortality Risks of Gastric Acid Suppressants in Patients Undergoing Peritoneal Dialysis","name":"articletitle","label":"Article Title"},{"value":"Kidney International Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ekir.2026.106991","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of the International Society of Nephrology.","name":"copyright","label":"Copyright"}],"article-number":"106991"}}